TAMPA, Fla.--(BUSINESS WIRE)--March 29, 2005--Anodyne(R) Therapy, LLC today announced the publication of a sixth peer-reviewed clinical study demonstrating restoration of sensation in the feet of patients with peripheral neuropathy. The purpose of the study was to measure improvements in patients’ ability to feel a standardized 10 gram Semmes-Weinstein Monofilament (SWM) test - the test deemed by Medicare in a 2001 Decision Memorandum to be the best measure of risk for diabetic ulcers amputations. The study appears in the March/April 2005 issue of The Journal of the American Podiatric Medical Association.
